Evidence map›Paper›PMID 34261889›Full record

ArticleJournal of addiction medicine

Recommendations to Inform Substance Use Disorder Data Sharing Research: Scoping Review and Thematic Analysis.

George Karway, Julia Ivanova, Anweysha Bhowmik, Anita Murcko, Michael Saks, Dennis McCarty, Aimee Campbell, Maria Adela Grando

Abstract readScoping Review
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Balancing Privacy, Trust, and Equity: Patient Perspectives on Substance Use Disorder Data Sharing.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
  6. FHIR Granular Sensitive Data Segmentation.Applied clinical informatics · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

George KarwayFrom the College of Health Solutions, Scottsdale, Arizona State University, Phoenix, AZ (GK, AB, AM, MAG); School of Human Evolution and Social Change, Arizona State University, Phoenix, AZ (JI); Sandra Day O'Connor College of Law, Arizona State University, Phoenix, AZ (MS); School of Public Health, Oregon Health & Science University, Portland, OR (DMcC); Department of Psychiatry, Columbia University, New York, NY (AC).
Julia Ivanova
Anweysha Bhowmik
Anita Murcko
Michael Saks
Dennis McCarty
Aimee Campbell
Maria Adela Grando

Funding

My Data Choices, evaluation of effective consent strategies for patients with behavioral health conditionsR01MH108992 · NIMH · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI GRANDO, MARIA ADELA · 2016 to 2020
$2.0M
NIMH NIH HHS R01 MH108992
6 · The paper itself

Abstract

objectivesTitle 42 Code of Federal Regulations Part 2 (42 CFR Part 2 or Part 2) was enacted in 1975 to protect patients receiving treatment for substance use disorders. A scoping review on Part 2 characterized published work.

methodsSeven databases were searched. Studies were categorized based on date of publication, primary objectives, methods, and findings. A thematic analysis was conducted using article titles and abstracts.

resultsOf the 36 studies identified, the majority (78%) were opinions or legal reviews, (22%) employed quantitative and/or qualitative methods to study the impact of Part 2, and over half (58%) were published in the past 5 years. Only 8% of studies reported stakeholder involvement in Part 2 studies and no study included patients or patient advocates. No study discussed the efforts to align Part 2 with Health Insurance Portability and Accountability Act or provided evidence of the benefit of this alignment. Three main themes emerged from the review: care delivery (46.6%), law and ethics (27.6%), and technology (25.9%). There were no studies focusing on stigma and its effect on substance use treatment and Part 2.

conclusionsDespite the significance of Part 2, the literature is sparse. It is time to initiate a new era of scholarly research that focuses on the impact of statutes and policies that govern substance use disorder data sharing. Specifically, we recommend research on Part 2 and Health Insurance Portability and Accountability Act alignment, the effects of Part 2 on patients, as well as providers and other stakeholder perceptions on the regulation.

Indexed as

Substance-Related DisordersHumansInformation Dissemination

Identifiers

PMID34261889
PMCPMC8755843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.